Literature DB >> 29772521

Myricetin attenuates neurodegeneration and cognitive impairment in Parkinsonism.

Vijayraja Dhanraj1, Jeyaprakash Karuppaiah2, Rengasamy Balakrishnan3, Namasivayam Elangovan3.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disease due to dopaminergic neuron degeneration. It mostly affects the aged population, leads to memory decline and loss of motor coordination. The present study investigates the neuroprotective role of myricetin a flavonol isolated from the brown seaweed Turbinaria ornata in rotenone induced Drosophila model of PD. Rotenone administration led to dopaminergic neuronal degeneration, dopamine depletion, impaired muscular coordination, gait disturbances, memory decline oxidative stress and apoptosis.  Ingestion of myricetin by Drosophila significantly prevented rotenone induced neuronal degeneration. These results confirm that myricetin exerts neuroprotective effect in experimental PD.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29772521     DOI: 10.2741/E835

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  5 in total

Review 1.  Seaweed Phenolics: From Extraction to Applications.

Authors:  João Cotas; Adriana Leandro; Pedro Monteiro; Diana Pacheco; Artur Figueirinha; Ana M M Gonçalves; Gabriela Jorge da Silva; Leonel Pereira
Journal:  Mar Drugs       Date:  2020-07-24       Impact factor: 5.118

2.  Unraveling Targetable Systemic and Cell-Type-Specific Molecular Phenotypes of Alzheimer's and Parkinson's Brains With Digital Cytometry.

Authors:  Marie C Bordone; Nuno L Barbosa-Morais
Journal:  Front Neurosci       Date:  2020-12-09       Impact factor: 4.677

Review 3.  Pharmacological Actions of Myricetin in the Nervous System: A Comprehensive Review of Preclinical Studies in Animals and Cell Models.

Authors:  Jie Li; Haitao Xiang; Chao Huang; Jiashu Lu
Journal:  Front Pharmacol       Date:  2021-12-16       Impact factor: 5.810

Review 4.  Experimental Models of Cognitive Impairment for Use in Parkinson's Disease Research: The Distance Between Reality and Ideal.

Authors:  Yaohua Fan; Jiajun Han; Lijun Zhao; Chunxiao Wu; Peipei Wu; Zifeng Huang; Xiaoqian Hao; YiChun Ji; Dongfeng Chen; Meiling Zhu
Journal:  Front Aging Neurosci       Date:  2021-11-29       Impact factor: 5.750

5.  Comparative Study of the Pharmacological Properties of Luteolin and Its 7,3'-Disulfate.

Authors:  Emma P Kozlovskaya; Aleksandr M Popov; Olga N Styshova; Aleksey I Vakhrushev; Tatyana A Rutckova; Anna B Podvolotskaya; Ludmila A Tekutyeva
Journal:  Mar Drugs       Date:  2022-06-28       Impact factor: 6.085

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.